Skip to main content

Tango Therapeutics, Inc 10-Q for FY2025 Q2

Tango Therapeutics, Inc. (TNGX)

10-Q 2025-08-05 For: 2025-06-30
View Original
Added on April 08, 2026

About this 10-Q

Tango Therapeutics, Inc filed this 10-Q on August 5, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.18M
down 84.0% from $19.88M a year earlier
Net loss
$38.85M
compared with a net loss of $25.55M a year earlier
Diluted EPS
-$0.35
compared with -$0.24 a year earlier